日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

State-of-the-Art on Model-Informed Drug Development Approaches for Pediatric Rare Diseases

儿科罕见病模型指导药物开发方法的最新进展

Krishna, Rajesh; Mitra, Amitava; Zierhut, Matthew L; East, Lilly; Durairaj, Chandra

Advancing pediatric drug development in South Asia: Current landscape and vision for the future

推进南亚儿科药物研发:现状与未来展望

Krishna, Rajesh; Jadhav, Manoj; Sivasubramanian, Rama; Sunkara, Gangadhar; Gota, Vikram; Niranjan, Vis; Dhote, Vipin; Sapkal, Nidhi; Rege, Nirmala N; Sethi, Samir; Medhi, Bikash; Kshirsagar, Nilima; Parmar, Deven

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受曲美利单抗单药治疗或联合度伐利尤单抗治疗的暴露-反应分析

Song, Xuyang; Kelley, Robin Kate; Khan, Anis A; Standifer, Nathan; Zhou, Diansong; Lim, KyoungSoo; Krishna, Rajesh; Liu, Lu; Wang, Kun; McCoon, Patricia; Negro, Alejandra; He, Philip; Gibbs, Megan; Kurland, John F; Abou-Alfa, Ghassan K

A Comparative Study on Predictive Validity of Modified Shock Index, Shock Index, and Age Shock Index in Predicting the Need for Mechanical Ventilation among Sepsis Patients in a Tertiary Care Hospital

改良休克指数、休克指数和年龄休克指数在预测三级医院脓毒症患者机械通气需求中的预测效度比较研究

Prasad, K J Devendra; Bindu, K C Hima; Abhinov, T; Moorthy, Krishna; Rajesh, K

Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure.

对 Ertugliflozin 非房室药代动力学参数进行荟萃分析,以评估剂量比例性和 UGT1A9 多态性对暴露的影响

Marshall Jean-Claude, Liang Yali, Sahasrabudhe Vaishali, Tensfeldt Thomas, Fediuk Daryl J, Zhou Susan, Krishna Rajesh, Dawra Vikas Kumar, Wood Linda S, Sweeney Kevin

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin

食物对厄格列净及其固定剂量复方制剂(厄格列净/西格列汀和厄格列净/二甲双胍)药代动力学的影响

Sahasrabudhe, Vaishali; Fediuk, Daryl J; Matschke, Kyle; Shi, Haihong; Liang, Yali; Hickman, Anne; Bass, Almasa; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas K

Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

艾格列净/西格列汀固定剂量复方片剂的生物等效性及其各组分不同规格联合用药的生物等效性

Fediuk, Daryl J; Matschke, Kyle; Liang, Yali; Pelletier, Kathleen B; Wei, Hua; Shi, Haihong; Bass, Almasa; Hickman, Anne; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

奥马利格列汀(一种每周一次的二肽基肽酶-4 (DPP-4) 抑制剂)在健康受试者中单次和多次给药后的药代动力学和药效学研究

Krishna, Rajesh; Addy, Carol; Tatosian, Daniel; Glasgow, Xiaoli S; Gendrano Iii, Isaias Noel; Robberechts, Martine; Haazen, Wouter; de Hoon, J N; Depré, Marleen; Martucci, Ashley; Peng, Joanna Z; Johnson-Levonas, Amy O; Wagner, John A; Stoch, S Aubrey

Spontaneous intraventricular rupture of pyogenic brain abscess: A short series of three cases and review of literature

自发性脑脓肿脑室内破裂:三例病例报告及文献复习

Savardekar, Amey R; Krishna, Rajesh; Arivazhagan, A

Novel magnetic resonance imaging scoring system for diagnosis of spinal tuberculosis: A preliminary report

一种用于诊断脊柱结核的新型磁共振成像评分系统:初步报告

Chandrasekhar, Yandrapati Bala Venkata Krishna; Rajesh, Alugolu; Purohit, Anirrudh Kumar; Rani, Yarralgadda Jyotsna